Bharat Biotech, Serum Institute of India ‘Not Considered’ for Emergency Use Authorisation Over Lack of Data

Bharat Biotech had applied to the Drugs Controller General of India seeking emergency use authorisation for its Covid-19 vaccine Covaxin. The Pune-based Serum Institute of India (SII) had applied to the central drug regulator for emergency use authorisation of AstraZeneca-Oxford’s coronavirus vaccine.